Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Otsuka Pharmaceutical Development & Commercialization, Inc.
Age
18–45
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy male and female subjects, ages 18 to 45 (WOCBP) must be using an adequate method of contraception to avoid pregnancy throughout the study and for up to 4 weeks after the study in such a manner that the risk of pregnancy is minimized.
Body Mass Index (BMI) of 18 to 33 kg/m2, inclusive.
You may not be if
Subjects with a decrease in SBP of \>=20 mm Hg and increase in HR of \>=20 bpm after 2 minutes standing vs. 2 minutes supine at screening or with frank orthostatic hypotension at screening.
Supine BP of 90/50 mm Hg or lower at screening
SBP \>=140 mm Hg or DBP \>=90 mm Hg at screening
Clareo Health | Aripiprazole and Effexor XR Drug Interaction Study
